Printer Friendly
The Free Library
19,607,050 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Eye Dynamics Has Record Profits and Sales in 2003.


Business Editors

TORRANCE, Calif.--(BUSINESS WIRE)--Jan. 22, 2004

Eye Dynamics, Inc. (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
:EYDY) completed year 2003 with its best ever sales and profits. Sales increased to $3.25 million, up 77% from the 2002 level of $1.84 million. Also, net profit increased to $856,000 as compared to $151,000 in 2002.

The increase in sales is due to successful marketing of its medical product to an expanding customer base of physicians by including Neurologists, Internal Medicine and Chiropractors to its mature market of ENT/Otologist physicians.

Overall expenses for 2003 decreased 6% from 2002 levels while sales increased 77%. Therefore, expenses, as a percent of revenue, were only 18% in 2003 as opposed to 34% in 2002.

For 2004, expansion into more medical markets is planned as well as closer cooperation with MedTrak Technologies, which accounted for 46% of revenues for the year, as they expand their product and market base.

For six consecutive quarters, sales have increased over the same quarter one year earlier. The goal for 2004 is to continue this string of successful quarterly periods. A continuing goal is to further increase gross profit by reducing product cost by upgrading designs and improved component selection. Eye Dynamics also plans to increase the selling price of select products.

This is the second consecutive year of profitability for Eye Dynamics. Earnings per share are estimated to be $0.05 per share or when fully diluted, $0.04 per share. The final Audited Financial Statement will be completed in February.

About Eye Dynamics, Inc.

Eye Dynamics is in the business of producing and marketing patented proprietary products and other services for the institutional, medical and government markets. The company is a leader in the Video ENG ENG electronystagmography.

ENG
abbr.
electronystagmography



ENG

enzootic nasal granuloma.
 medical product market, having invented the Video ENG system and brought it to market in 1994. SafetyScope, the company's latest product, is designed for the 'fitness-for-duty' screening of workers. SafetyScope is simple to use, takes only 90 seconds and does not require any bodily fluids like urine-based drug testing. It is based on the manual methods of evaluating eye responses of an individual to detect neurological neurological, neurologic

pertaining to or emanating from the nervous system or from neurology.


neurological assessment
evaluation of the health status of a patient with a nervous system disorder or dysfunction.
 signs of impairment used by law enforcement throughout the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. .

To find out more about Eye Dynamics, Inc. (OTC OTC

See: Over-the-counter.


OTC

See over-the-counter market (OTC).
:EYDY), visit our web site at www.EYEDYNAMICS.COM (1) (Computer Output Microfilm) Creating microfilm or microfiche from the computer. A COM machine receives print-image output from the computer either online or via tape or disk and creates a film image of each page.  

Safe Harbor Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
 for Forward Looking Statements

This news release includes forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
 that are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jan 22, 2004
Words:510
Previous Article:Fitch Affirms Fluor's 'A/F1' Ratings; Revises Outlook to Negative.
Next Article:NSTAR Reports Earnings for the Fourth Quarter and Year 2003.



Related Articles
Dynamic approach.
FLIPPING HOMES IN STATE DOWN PRACTICE AT LOWEST LEVEL SINCE 2003.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles